Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05573386 · ClinicalTrials.gov registry record
Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim
A clinical trial, sponsored by Andrews Research & Education Foundation.
- Completed
- Registry status
- 15
- Enrollment target
NCT05573386 is a clinical trial that has completed, run by Andrews Research & Education Foundation. The registered enrollment target is 15 participants.
The verdict
NCT05573386 has completed, sponsored by Andrews Research & Education Foundation.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The goal of this prospective, observational study is to compare the quality and quantity of the cellular content of platelet-rich plasma harvested after administering one of two cell-stimulating proteins, filgrastim and pegfilgrastim. The main question it aims to answer is: • Will participants have a similar cellular content when comparing a 4-day filgrastim treatment to a one-day pegfilgrastim treatment? Participants will have the following intervention administered: * 130mL of blood will be drawn on the first visit after consent and in followup visits after administering treatment (4 days for filgrastim, 7 days for pegfilgrastim) * Half of all participants will receive filgrastim first, followed by pegfilgrastim 8 weeks after filgrastim treatment concludes. The other half will receive the treatments in reverse order Researchers will compare the quality and quantity of cell content after each treatment administration as well as comparing differences in data dependent on which order treatment was given.
Interventions
- DRUG Filgrastim
- DRUG Pegfilgrastim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2023-10-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05573386
The ClinicalTrials.gov registry entry for NCT05573386 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrews Research & Education Foundation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Filgrastim is the first listed.
NCT05573386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05573386 about?
NCT05573386 is a clinical study titled "Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim". The goal of this prospective, observational study is to compare the quality and quantity of the cellular content of platelet-rich plasma harvested after administering one of two cell-stimulating proteins, filgrastim and pegfilgrastim. The main question it aims to answer is: • Will participants have...
What is the current status of trial NCT05573386?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-08-09. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT05573386?
The interventions under investigation include: Filgrastim (DRUG), Pegfilgrastim (DRUG).
Who is sponsoring clinical trial NCT05573386?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.